• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by NANO-X IMAGING LTD

    11/19/25 8:38:30 AM ET
    $NNOX
    Medical Electronics
    Health Care
    Get the next $NNOX alert in real time by email
    6-K 1 ea0266391-6k_nano.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of November 2025

     

    Commission File Number: 001-39461

     

    NANO-X IMAGING LTD

     

    Ofer Tech Park

    94 Shlomo Shmeltzer Road

    Petach Tikva

    Israel 4970602

    (Address of principal executive office)

       

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒     Form 40-F ☐

     

     

     

     

     

     

    On November 19, 2025, NANO-X IMAGING LTD issued a press release, a copy of which is attached hereto as Exhibit 99.1, and incorporated herein by reference.

     

    1

     

     

    EXHIBIT INDEX

     

    Exhibit No.  Exhibit
    99.1  Press release, dated November 19, 2025.

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      NANO-X IMAGING LTD
       
      By: /s/ Ran Daniel
      Name:  Ran Daniel
      Title: Chief Financial Officer

     

    Date: November 19, 2025

     

    3

     

    Get the next $NNOX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NNOX

    DatePrice TargetRatingAnalyst
    1/6/2025$23.00Buy
    D. Boral Capital
    9/8/2023$14.50Buy
    Alliance Global Partners
    1/5/2023$21.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $NNOX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Daniel Ran bought $3,650 worth of Ordinary shares (1,000 units at $3.65), increasing direct ownership by 17% to 6,950 units (SEC Form 4)

    4 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    9/5/25 5:41:26 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    SEC Filings

    View All

    SEC Form 424B5 filed by NANO-X IMAGING LTD

    424B5 - Nano-X Imaging Ltd. (0001795251) (Filer)

    11/25/25 4:39:36 PM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 6-K filed by NANO-X IMAGING LTD

    6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

    11/20/25 8:05:18 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 6-K filed by NANO-X IMAGING LTD

    6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

    11/19/25 8:38:30 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    D. Boral Capital initiated coverage on Nano-X Imaging with a new price target

    D. Boral Capital initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $23.00

    1/6/25 9:02:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Alliance Global Partners initiated coverage on Nano-X Imaging with a new price target

    Alliance Global Partners initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $14.50

    9/8/23 9:14:06 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Cantor Fitzgerald initiated coverage on Nano-X Imaging with a new price target

    Cantor Fitzgerald initiated coverage of Nano-X Imaging with a rating of Overweight and set a new price target of $21.00

    1/5/23 7:46:34 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nanox Engages with Althea France to Accelerate European Commercialization of Nanox.ARC System

    Althea France, part of one of Europe's largest independent medical technology services providers, to distribute CE-marked Nanox.ARC system across French healthcare sector Partnership represents Nanox's fourth European distribution agreement following recent collaborations in Greece, Romania and Czech Republic PETACH TIKVA, ISRAEL – November 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company", NASDAQ:NNOX), an innovative medical imaging technology company, today announced a distribution collaboration with Althea France SARL ("Althea France"), part of the Althea Group, one of Europe's largest independent providers of managed medical technology services, to introduce Na

    11/25/25 8:10:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox.AI Bone Solutions, Advanced AI-Powered Software for Spine Assessment, Recommended by NICE for Early Value Assessment in UK National Health Service hospitals

    Nanox's HealthOST and HeathVCF recommended for use in UK National Health Service hospitals for a three-year period as the use of AI solutions in bone disease is evaluated PETACH TIKVA, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company", NASDAQ:NNOX), an innovative medical imaging technology company today announced that its deep-learning medical imaging analytics subsidiary, Nanox.AI Ltd ("Nanox. AI", secured the recommendation of the National Institute for Health and Care Excellence (NICE), the UK's clinical standards and reimbursement body. NICE has included both Nanox AI bone solutions in an Early Value Assessment at National Health Service (NHS) hospi

    11/24/25 8:10:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox Announces $15 Million Registered Direct Offering of Common Stock

    PETACH TIKVA, Israel, Nov. 23, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company", NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 3,826,530 ordinary shares ("Common Stock") in a registered direct offering. The offering is expected to result in gross proceeds of approximately $15 million, before deducting offering expenses. The closing of the offering is expected to occur on or about November 25, 2025, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the of

    11/23/25 11:26:08 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Daniel Ran bought $3,650 worth of Ordinary shares (1,000 units at $3.65), increasing direct ownership by 17% to 6,950 units (SEC Form 4)

    4 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    9/5/25 5:41:26 PM ET
    $NNOX
    Medical Electronics
    Health Care

    New insider Daniel Ran claimed ownership of 5,950 units of Ordinary Shares (SEC Form 3)

    3 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    9/5/25 2:11:14 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Financials

    Live finance-specific insights

    View All

    Nanox Announces Third Quarter of 2025 Financial Results and Provides Business Update

    Management to host conference call and webcast Thursday, November 20, 2025, at 8:30 AM ET Company advances commercialization and is on track to meet year-end system deployment target PETAH TIKVA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2025, and provided a business update. Recent Highlights: Generated $3.4 million in revenue in the third quarter of 2025, compared to $3.0 million in the third quarter of 2024.Acquired 100% of the stock of Vaso Healthcare IT, a provider of healthcare information technologies solu

    11/20/25 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox to Report Third Quarter 2025 Financial Results on November 20, 2025

    PETACH TIKVA, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2025, before market open on Thursday, November 20, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link:  Nanox Q3 2025 Conference Call. The live webcast of the conference call may be ac

    11/7/25 4:05:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox Announces Second Quarter of 2025 Financial Results and Provides Business Update

    Management to host conference call and webcast Tuesday, August 12, 2025 at 8:30 AM ET Company continued to grow Nanox.ARC installed base and is on track to meet its year-end system deployment target PETAH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2025 and provided a business update. Recent Highlights: Generated $3.0 million in revenue in the second quarter of 2025, compared to $2.7 million in the second quarter of 2024.Grew Nanox.ARC system sales funnel exponentially in the quarter.The Company notified the FD

    8/12/25 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Leadership Updates

    Live Leadership Updates

    View All

    Nanox Announces Appointment of Medical Executive Moshe Shtengel as Chief Business Officer

    NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) -- NANOX IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021. Mr. Shtengel joins Nanox from Tuttnauer, a global manufacturer of sterilizers and infection control systems for medical institutions, where he served as Vice President of Global Sales, Marketing and Products. "Moshe is an extremely seasoned sales and business development executive with a proven track record of success and leadership in the medical field," stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. "As we

    5/3/21 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    3/7/24 12:29:51 PM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form SC 13G filed by NANO-X IMAGING LTD

    SC 13G - Nano-X Imaging Ltd. (0001795251) (Subject)

    2/6/24 9:36:34 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    2/14/23 4:15:16 PM ET
    $NNOX
    Medical Electronics
    Health Care